F432-0575 Screening compound: N-{6-[(4-chlorophenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-3,4-difluorobenzene-1-sulfonamide

F432-0575 Screening compound: N-{6-[(4-chlorophenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-3,4-difluorobenzene-1-sulfonamide
F432-0575 Screening compound: N-{6-[(4-chlorophenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-3,4-difluorobenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F432-0575
N-{6-[(4-chlorophenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-3,4-difluorobenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F432-0575

Molecular Formula

C21H16ClF2N3O3S2 (C21 H16 ClF2 N3 O3 S2)

Compound Name

N-{6-[(4-chlorophenyl)sulfanyl]-1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl}-3,4-difluorobenzene-1-sulfonamide

IUPAC name

N-{6-[(4-chlorophenyl)sulfanyl]-13-dimethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl}-34-difluorobenzene-1-sulfonamide

SMILES

CN(c(c(N1C)c2)cc(NS(c(cc3)cc(F)c3F)(=O)=O)c2Sc(cc2)ccc2Cl)C1=O

InChI

InChI=1S/C21H16ClF2N3O3S2/c1-26-18-10-17(25-32(29,30)14-7-8-15(23)16(24)9-14)20(11-19(18)27(2)21(26)28)31-13-5-3-12(22)4-6-13/h3-11,25H,1-2H3

InChI Key

CSFFAPCALWVCQH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27128598

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.96

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.542

Distribution Coefficient, logD

5.514

Water Solubility, LogSw

-5.93

Polar Surface Area

57.603

Acid Dissociation Constant (pKa)

8.58

Base Dissociation Constant (pKb)

-2.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.50

F432-0575 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F432-0575 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F432-0575?
Check Price and Availability of F432-0575, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F432-0575 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F432-0575
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F432-0575
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F432-0575 available by request